ArticleJournal of clinical medicine research2023

Oral Semaglutide Induces Loss of Body Fat Mass Without Affecting Muscle Mass in Patients With Type 2 Diabetes.

Syutaro Uchiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.